BioSig Technologies, Inc.

Common Stock SEC Reporting - Current
Contact Info
  • 8441 Wayzata Blvd.
  • Suite 240
  • Minneapolis, MN 55426

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001530766
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3845 - Electromedical equipment
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. 2009
Employees 10 a/o May 04, 2015
Company Officers/Contacts
Gregory D Cash CEO
Steve Chaussy CFO
Company Directors
Kenneth L Londoner Chairman
Gregory D Cash
Seth H. Z. Fischer
Donald E. Foley
Patrick J. Gallagher
David Weild IV
Jeffrey F. O'Donnell, Sr.
Roy T Tanaka
Jerome B. Zeldis
Service Providers
Accounting/Auditing Firm
Liggett & Webb, P.A.
432 Park Avenue South, 10 Floor
New York, NY, 10016
United States

Legal Counsel
Haynes and Boone, LLP
30 Rockefeller Plaza
26th Floor
New York, NY, 10510
United States

Investor Relations Firm
Barry Kaplan Associates
623 River Rd.
Suite 200
Fair Haven, NJ, 07704
United States

Financial Profiles, Inc.
11601 Wilshire Blvd, Suite 1920
Los Angeles, CA, 90025
United States

BSGM Security Details
Share Structure
Market Value1 $28,073,125 a/o Dec 02, 2016
Authorized Shares 40,000,000 a/o Sep 30, 2016
Outstanding Shares 20,950,093 a/o Nov 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 7,755,079 a/o May 10, 2016
Par Value 0.001
Shareholders of Record 775 a/o May 10, 2016
Short Selling Data
Short Interest 9,626 (101.85%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security